MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q1
hinzugefügt 01.05.2025
Blueprint Medicines Corporation ROA 2011-2026 | BPMC
ROA Jährlich Blueprint Medicines Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.69 | -48.32 | -41.3 | -51.44 | 18.27 | -49.13 | -43.81 | -20.69 | -25.64 | -29.5 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 18.27 | -51.44 | -29.72 |
ROA Vierteljährlich Blueprint Medicines Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.49 | -0.26 | -12.36 | -19.77 | -27.61 | -34.72 | -43.85 | -40.88 | -38.15 | -27.67 | -35.61 | -25.14 | -32.06 | -20.98 | 15.91 | 60.74 | 60.47 | 23.25 | 13.88 | -36.34 | -43.24 | -49.13 | -54.63 | -54.77 | -45.69 | -43.81 | -35.79 | -27.59 | -27.26 | -20.69 | -21.36 | -22.05 | -24.06 | -25.64 | -26.82 | -27.94 | -28.51 | -29.5 | -49.77 | -63.74 | -73.08 | -80.69 | -51.71 | -30.67 | -14.08 | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 60.74 | -80.69 | -26.82 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
ADMA Biologics
ADMA
|
23.54 | $ 16.62 | 1.47 % | $ 3.96 B |  USA |
 |
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M |  Germany |
 |
ANI Pharmaceuticals
ANIP
|
-1.44 | $ 77.07 | 1.27 % | $ 1.49 B | USA |
 |
Apellis Pharmaceuticals
APLS
|
2.08 | $ 20.12 | -0.2 % | $ 2.54 B | USA |
 |
Aptorum Group Limited
APM
|
-26.46 | $ 0.81 | 2.62 % | $ 4.42 M |  China |
 |
Graybug Vision
GRAY
|
-217.51 | - | -11.23 % | $ 9.65 M | USA |
 |
Axsome Therapeutics
AXSM
|
-26.55 | $ 164.87 | 0.5 % | $ 8.2 B | USA |
 |
AbCellera Biologics
ABCL
|
-10.79 | $ 3.72 | 0.13 % | $ 1.11 B |  Canada |
 |
I-Mab
IMAB
|
7.43 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | USA |
 |
Acer Therapeutics
ACER
|
-225.71 | - | 2.71 % | $ 14 M | USA |
 |
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M |  France |
 |
Ampio Pharmaceuticals
AMPE
|
-150.49 | - | -11.43 % | $ 502 K | USA |
 |
BioLineRx Ltd.
BLRX
|
-33.24 | $ 2.84 | 1.07 % | $ 908 M |  Israel |
 |
Athersys
ATHX
|
-144.48 | - | 3.77 % | $ 22.4 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
-42.28 | - | -18.52 % | $ 27.3 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
-50.64 | - | - | $ 521 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
4.59 | $ 61.12 | 4.43 % | $ 11.7 B | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
-634.44 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
26.14 | - | -4.8 % | $ 255 M | USA |
 |
Burford Capital Limited
BUR
|
5.51 | $ 8.38 | -1.99 % | $ 1.39 B | Britain |
 |
Cabaletta Bio
CABA
|
-26.68 | $ 3.42 | 5.08 % | $ 3.99 M | USA |
 |
BridgeBio Pharma
BBIO
|
-78.3 | $ 67.08 | 3.95 % | $ 12.8 B | USA |
 |
Adverum Biotechnologies
ADVM
|
-72.8 | - | - | $ 86.2 M | USA |
 |
CymaBay Therapeutics
CBAY
|
-24.24 | - | - | $ 3.45 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - |  Russia |
 |
Avid Bioservices
CDMO
|
-41.82 | - | - | $ 789 M | USA |
 |
ARCA biopharma
ABIO
|
-21.14 | - | 1052.0 % | $ 415 M | USA |
 |
Codexis
CDXS
|
-43.81 | $ 1.1 | 11.73 % | $ 80.7 M | USA |
 |
Checkpoint Therapeutics
CKPT
|
-752.78 | - | - | $ 169 M | USA |
 |
Caladrius Biosciences
CLBS
|
-57.1 | - | -16.75 % | $ 25.8 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-20.15 | - | - | $ 2.17 B | USA |
 |
Clovis Oncology
CLVS
|
-55.94 | - | -7.23 % | $ 13 M | USA |
 |
Acorda Therapeutics
ACOR
|
-232.99 | - | -24.86 % | $ 820 K | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
-77.89 | - | - | $ 231 M | USA |
 |
Coherus BioSciences
CHRS
|
-37.78 | $ 1.8 | 8.79 % | $ 169 M | USA |
 |
Acasti Pharma
ACST
|
-13.29 | - | 4.01 % | $ 150 M | Canada |
 |
CTI BioPharma Corp.
CTIC
|
-73.85 | - | - | $ 1.2 B | USA |
 |
CohBar
CWBR
|
-74.39 | - | -15.44 % | $ 2.2 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
-273.86 | - | -5.98 % | $ 34.1 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-273.86 | - | -4.36 % | $ 27 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
-41.16 | - | - | $ 2.18 B | USA |
 |
CureVac N.V.
CVAC
|
-35.55 | - | - | $ 867 M | Germany |
 |
Capricor Therapeutics
CAPR
|
-37.95 | $ 26.34 | 1.93 % | $ 705 M | USA |
 |
Aeterna Zentaris
AEZS
|
-10.45 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-123.72 | - | -10.17 % | $ 12.2 K | USA |
 |
Certara
CERT
|
-0.1 | $ 7.25 | 0.14 % | $ 1.16 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | USA |
 |
Champions Oncology
CSBR
|
14.53 | $ 6.05 | 0.83 % | $ 82.6 M | USA |